BR9710826A - Process for the production of epsilon interferon from human amniotic membrane and protein from human epsilon interferon from human amniotic membrane - Google Patents
Process for the production of epsilon interferon from human amniotic membrane and protein from human epsilon interferon from human amniotic membraneInfo
- Publication number
- BR9710826A BR9710826A BR9710826A BR9710826A BR9710826A BR 9710826 A BR9710826 A BR 9710826A BR 9710826 A BR9710826 A BR 9710826A BR 9710826 A BR9710826 A BR 9710826A BR 9710826 A BR9710826 A BR 9710826A
- Authority
- BR
- Brazil
- Prior art keywords
- human
- interferon
- amniotic membrane
- epsilon
- protein
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Patente de Invenção para <B>"PROCESSO PARA PRODUçãO DO INTERFERON EPSILON DE MEMBRANA AMNIóTICA HUMANA E PROTEìNA DO INTERFERON EPSILON HUMANO DE MEMBRANA AMNIóTICA HUMANA<D> A presente invenção diz respeito ao processo de produção de proteina de interferon epsilon de membrana amniótica humana para ser empregada em uso clínico humano ou veterinário ou em pesquisa e da proteína interferon epsilon caracterizado por não ser neutralizada por anticorpos anti-interferon beta humano. As placentas foram coletadas em solução salina, as membranas amnióticas foram removidas e fragmentadas. As membranas foram infectadas com vírus, e o interferon foi coletado após 24 e 48 horas.O interferon epsilon foi concentrado e fracionado em coluna de afinidade e não se liga a anticorpos anti-interferon beta humano.Invention Patent for <B> "PROCESS FOR THE PRODUCTION OF THE HUMAN AMNIOTIC MEMBRANE INTERFERON EPSILON AND THE HUMAN AMNIOTIC MEMBRANE INTERFERON EPSILON <D> The present invention relates to the production process of human epsilon interferon protein for human amniotic membrane be used in clinical human or veterinary use or in research and the interferon epsilon protein characterized by not being neutralized by anti-human beta interferon antibodies.The placentas were collected in saline, the amniotic membranes were removed and fragmented. virus, and interferon was collected after 24 and 48 hours. Epsilon interferon was concentrated and fractionated in an affinity column and does not bind to human anti-interferon beta antibodies.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR9710826A BR9710826A (en) | 1997-10-16 | 1997-10-16 | Process for the production of epsilon interferon from human amniotic membrane and protein from human epsilon interferon from human amniotic membrane |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR9710826A BR9710826A (en) | 1997-10-16 | 1997-10-16 | Process for the production of epsilon interferon from human amniotic membrane and protein from human epsilon interferon from human amniotic membrane |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9710826A true BR9710826A (en) | 2001-06-26 |
Family
ID=4068863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9710826A BR9710826A (en) | 1997-10-16 | 1997-10-16 | Process for the production of epsilon interferon from human amniotic membrane and protein from human epsilon interferon from human amniotic membrane |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BR9710826A (en) |
-
1997
- 1997-10-16 BR BR9710826A patent/BR9710826A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Domont et al. | Natural anti-snake venom proteins | |
| KR920000789A (en) | Fusion protein having an immunoglobulin moiety, method for preparing the same, and use thereof | |
| KR930701601A (en) | O-glycosylated IFN-alpha | |
| BR0114475A (en) | Cell for the production of antibody composition | |
| KR950032279A (en) | Peptides Related to Programmed Cell Death in the Human Body and DNA Encoding them | |
| DK1062325T3 (en) | Purification of virus preparations | |
| BR9711457A (en) | Compounds and process for the treatment and diagnosis of mycobacterial infections. | |
| ATE176156T1 (en) | HUMAN INTRA-ACROSOMAL SPERM ANTIGEN FOR USE IN A CONTRACEPTIVE VACCINE | |
| PT96097A (en) | PROCESS FOR THE PREPARATION OF TOXOPLASMA GONDII ANTIGEN AS WELL AS DIAGNOSTIC MEDIA, VACCINES AND ANTIBODIES OF THE DERIVATIVES | |
| PT98805A (en) | A method of preparing a novel binding protein to the insulin-like growth factor (IGFBP-5) | |
| DE69132795T2 (en) | CLEANED GP120 WHICH GETS ITS NATURAL INFORMATION | |
| PT98669A (en) | PROCESS FOR THE PREPARATION OF THE PROTEIN STRUCTURE OF VEGETABLE GELONINE TOXIN | |
| BR0016212A (en) | Sex chromosome-specific protein and isolated and purified nucleic acid sequence, method for identifying specific sex chromosome molecules associated with animal sperm cell membranes, antibody against an epitope of a specific sex chromosome molecule, screening methods for a specific molecule of sex chromosomes, and to separate male and female determinant sperm from native semen kit to perform a method, contraceptive, isolated and purified sex chromosome-specific protein, and molecule | |
| PT98804A (en) | IGFBP-4 PREPARATION PROCESS OR A FRAGMENT OF THE SAME | |
| Bhanushali et al. | Simple method to purify chicken immunoglobulin G | |
| DE69530689D1 (en) | HEPARIN BINDING PROTEIN FOR TREATING SEPSIS | |
| BR9710826A (en) | Process for the production of epsilon interferon from human amniotic membrane and protein from human epsilon interferon from human amniotic membrane | |
| ATE139541T1 (en) | COLLAGEN-BINDING PROTEIN AND THE PRODUCTION THEREOF | |
| EP0258111A3 (en) | Novel neuronotrophic factor | |
| ATE103989T1 (en) | MONOCLONAL ANTIBODIES TO E7 PROTEIN OF HUMAN PAPILLOMVIRUS TYPE 16, PROCESS FOR THEIR PRODUCTION AND THEIR USE. | |
| ATE91304T1 (en) | PROCEDURE FOR THE PRODUCTION OF PRES 1/S2/SHEPATITIS B ANTIGEN FROM YEAST. | |
| PT88913A (en) | PROCESS FOR THE PREPARATION OF ANTICOAGULANT PP4-X PROTEIN | |
| EP0327769A3 (en) | Novel neuronotrophic factor | |
| DE69631624D1 (en) | ANTIBODIES AGAINST HUMAN RESTRICTIN | |
| Perepechkina et al. | Efficient molecular mass fractionation of leukocyte extract by membrane separation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
| B15Z | Prolongation of time limit refused |
Free format text: NEGADA A SOLICITACAO DE DEVOLUCAO DE PRAZO UMA VEZ QUE A MESMA NAO FOI APRESENTADA AO INPI NA VIGENCIA DO PRAZO PREVISTO PARA A PRATICA DO ATO, CONFORME DEFINIDO NO ART. 221 DA LPI. A COPIA DO PARECER (DAS RAZOES) PODERA SER SOLICITADA ATRAVES DO FORMULARIO 1.05. (DESTA DATA CORRE O PRAZO DE 60 (SESSENTA) DIAS PARA EVENTUAL RECURSO DO INTERESSADO). |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: ASSIM, DE ACORDO COM O ART.36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. |
|
| B12F | Other appeals [chapter 12.6 patent gazette] | ||
| B08E | Application fees: payment of additional fee required [chapter 8.5 patent gazette] |
Free format text: CONFORME RESOLUCAO 124/06, O DEPOSITANTE DEVERA COMPLEMENTAR A RETRIBUICAO DA 9A, 11A E 13A ANUIDADES, REFERENTE AS GUIAS DE RECOLHIMENTO 22060109829-0, 22080088210-2 E 22100146693-9, RESPECTIVAMENTE, E COMPROVAR RECOLHIMENTO REFERENTE AS 12A, 14A E 15A ANUIDADES. |
|
| B08L | Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette] |
Free format text: ARQUIVAMENTO DEFINITIVO |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 38/21 (2006.01), C07K 14/555 (2006.0 |
|
| B08I | Publication cancelled [chapter 8.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2243 DE 31/12/2013 POR TER SIDO INDEVIDA. |
|
| B08E | Application fees: payment of additional fee required [chapter 8.5 patent gazette] |
Free format text: COMPLEMENTAR A RETRIBUICAO DA 9A,11A E 13A ANUIDADES DE ACORDO COM A TABELA VIGENTE REFERENTE A GUIA DE RECOLHIMENTO GRU 0000220601098290,0000220800882102 E 0000221001466939, RESPECTIVAMENTE. COMPROVAR AS ANUIDADES EM DEBITO. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AO NAO CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI 2611, DE 19/01/2021. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2632 DE 15/06/2021. |